NovaBay Pharmaceuticals, Inc. (NYSE:NBY) announced Monday its corporate name change to Stablecoin Development Corporation, signaling a full shift toward a cryptocurrency-focused strategy.From Pharms To CryptoThe biotech firm will also adopt a new ticker symbol, SDEV, which is expected to take effect on April 3, according to the press release.The company’s CEO, Michael Kazley, stated, “The name change to Stablecoin Development Corporation reflects our conviction that stablecoins represent the most compelling ...

NovaBay Rebrands To Stablecoin Development Corp, Shares Jump 12 Percent Shares of NovaBay Pharmaceuticals (NYSE: $NBY) were up over 12 percent on Monday after the company said it will rebrand as Stablecoin Development Corporation and update the company stock symbol to "SDEV" starting on Friday, April 3. The California based firm, which divested its legacy eyecare and wound care brands late last year will focus exclusively on the Sky (CRYPTO: $SKY) protocol ecosystem, a decentralized financial infrastructur ...

Token Holdings - As of March 16, 2026, the company holds approximately 2.06 billion SKY tokens, reflecting its engagement in SKY-related on-chain activities, including staking[3] Corporate Name Change - The company will change its name to "Stablecoin Development Corporation," with trading under the new name expected to begin on April 3, 2026[5] Stock Ticker Change - The company's common stock will cease trading under the ticker symbol "NBY" and will commence trading under the ticker symbol "SDEV" effective April 3, 2026[7]

Following $134 million investment from R01 Fund LP, Framework Ventures, Tether Investments, S.A. de C.V., and Sky Frontier Foundation, Stablecoin Development Corporation has acquired 2.06 billion SKY tokens Key Highlights: Corporate name change from NovaBay Pharmaceuticals, Inc. to Stablecoin Development Corporation; ticker symbol change from NBY to SDEV on the NYSE American, expected to be effective on Friday, April 3, 2026Approximately 2.06 billion SKY tokens held as of March 16, 2026, representing approx ...

Financial Performance - The company reported a net loss from continuing operations of $33.2 million for the year ended December 31, 2025, compared to a net loss of $8.8 million in 2024, representing a 280% increase in losses [262]. - Total operating expenses increased by 14% to $8.4 million in 2025, up from $7.4 million in 2024 [262]. - The company recorded a net loss from continuing operations of $33.2 million for the year ended December 31, 2025, compared to a net loss of $8.8 million for 2024 [269]. - Net cash used in operating activities from continuing operations was $8.4 million for the year ended December 31, 2025, compared to $7.5 million for 2024 [272][273]. - The company incurred a non-cash loss of $24.5 million related to changes in the fair value of warrant liabilities for the year ended December 31, 2025 [266]. - The company reported a non-cash loss of $24.5 million on changes in the fair value of warrant liability, a significant increase compared to a gain of $0.1 million in 2024 [262]. Cash and Liquidity - Cash and cash equivalents increased to $8.0 million as of December 31, 2025, up from $0.4 million at the end of 2024 [269]. - The company anticipates that existing cash and cash equivalents will be sufficient to fund planned operating expenses at least through March 19, 2027 [250]. - The company expects existing cash and cash equivalents, along with anticipated gross cash proceeds of approximately $25.0 million from a private placement, to fund operating expenses at least through March 19, 2027 [270]. - Net cash provided by financing activities from continuing operations was $4.6 million for the year ended December 31, 2025, compared to $1.5 million for 2024 [275][276]. Asset Management - The company completed a January 2026 Private Placement, issuing pre-funded warrants for approximately $25.0 million in cash, 35,000,000 USDT, and 16,000,000 USDS stablecoins, totaling an aggregate value of approximately $51.0 million [239]. - The company deployed approximately $70.7 million in cash to acquire approximately 1.1 billion SKY tokens following the January 2026 Private Placement [251]. - The company deployed approximately $70.7 million in cash to acquire about 1.1 billion SKY tokens following the January 2026 Private Placement [271]. - The company recorded an impairment of $854 thousand related to right-of-use assets and fixed assets due to strategic realignment [265]. - As of March 16, 2026, the company held approximately 2.1 billion SKY tokens, a network-native digital asset [241]. Strategic Initiatives - The company has not established a specific target allocation for SKY or other digital assets, with decisions driven by market conditions and risk controls [240]. - The company completed several divestitures, including the Avenova Asset and PhaseOne Divestitures, which are reflected as discontinued operations in the financial statements [249]. - The company is exposed to market price volatility associated with digital assets as it implements its digital asset strategy [287]. Expenses - General and administrative expenses rose by 3% to $7.6 million in 2025, primarily due to higher legal costs associated with strategic initiatives [264]. - The company had federal and state net operating loss carryforwards of approximately $2.9 million and $348 thousand, respectively, as of December 31, 2025 [278].

Summary of NovaBay Pharmaceuticals 2026 Special Meeting Company Overview - **Company Name**: NovaBay Pharmaceuticals, Inc. (NYSEAM:NBY) - **Meeting Date**: March 12, 2026 - **Meeting Type**: Special Meeting of Stockholders Key Points Discussed Meeting Structure - The meeting was presided over by Michael Kazley, CEO and Chairman of the Board, with other board members and guests participating virtually [2][3] - The meeting included a formal session to address official business and a subsequent informal Q&A session [4] Voting Proposals 1. **Private Placement Issuance Proposal** - Approval for the issuance of 837,696,130 shares of common stock upon exercise of pre-funded warrants from the January 2026 private placement [9] - The board recommended approval [11] 2. **October Warrant Share Issuance Proposal** - Approval for the issuance of 5,405,406 shares of common stock upon exercise of pre-funded warrants from October 2025 [12] - The board recommended approval [14] 3. **Written Consent Proposal** - Amendment to the certificate of incorporation to permit stockholder action by written consent [15] - The board recommended approval [16] 4. **Officer Exculpation Proposal** - Amendment to provide for officer exculpation under Delaware law [17] - The board recommended approval [18] 5. **Authorized Common Stock Proposal** - Increase the number of authorized shares of common stock from 1.5 billion to 5.0 billion [19] - The board recommended approval [20] 6. **Equity Incentive Plan Proposal** - Approval of the 2026 equity incentive plan [22] - The board recommended approval [22] Voting Results - A quorum was established with approximately 96.73% of voting power represented [7] - All six proposals were approved by stockholders [24] Additional Important Information - The record date for stockholders entitled to vote was February 10, 2026 [5] - The meeting included a formal voting process where stockholders could vote in person or by proxy [11][20] - The meeting concluded with an invitation for questions from stockholders, indicating a focus on transparency and engagement [25]

Core Viewpoint - NioBay Metals Inc. has released a new resource estimate for the Crevier niobium and tantalum project, marking a significant update from the previous estimate in 2010, with improved resource classification and economic modeling [1][2][9]. Overview of the 2026 MRE - The 2026 Mineral Resource Estimate (MRE) was conducted by IOS Geoscientific Services and adheres to NI 43-101 regulations, incorporating updated drilling data and metallurgical tests from 2022 to 2025 [2][8]. - The estimate includes a major revision of production costs and various selling price scenarios, focusing on marketing niobium as a specialty product [2][7]. Resource Classification - The new estimate has converted 16,257,000 tons at 0.17% Nb₂O₅ and 201 ppm Ta₂O₅ into measured resources, a category that was previously undefined in the 2010 estimate [3][5]. - The comparative parameters show that the total measured and indicated resources have increased to 20,733,000 tons with a consistent Nb₂O₅ grade of 0.17% [5]. Economic Considerations - The resource estimate is based on an optimized pit shell and includes a preliminary production cost estimate derived from metallurgical tests [7][14]. - The cut-off grade for reporting was calculated using a niobium price of US$82/kg, with a corresponding cut-off grade of 0.1124% Nb₂O₅ equivalent [14]. Future Prospects - The Crevier project is positioned to potentially focus exclusively on producing niobium oxide for battery and superalloy manufacturers, indicating a strategic direction for the company [10]. - The updated resource estimate is seen as a key milestone for NioBay in discussions with potential clients and partners, enhancing the foundation for future fieldwork [9]. Company Background - NioBay Metals aims to lead in low carbon consumption mining practices while ensuring the participation of Indigenous communities in its operational territories [13]. - The company holds a 72.5% interest in the Crevier project and a 100% interest in the James Bay Niobium Project [13].

Core Viewpoint - NioBay Metals Inc. is positioning itself as a future North American supplier of niobium and other strategic metals critical to the green energy revolution, with a focus on advancing its key projects in Ontario and Québec [3]. Company Overview - NioBay Metals aims to lead in the development of mines with low carbon consumption and responsible management practices, prioritizing environmental and social responsibility [5]. - The company holds a 100% interest in the James Bay Niobium Project in Ontario and a 72.5% interest in the Crevier Niobium and Tantalum project in Québec [5]. Upcoming Events - NioBay will present at Red Cloud's Pre-PDAC Mining Showcase on February 26-27, 2026, with CEO Jean-Sébastien David and CFO Anthony Glavac providing updates on the company's strategy and developments [2][4]. Strategic Focus - The company is advancing its niobium assets to meet the growing demand for secure North American supplies of niobium and tantalum, which are essential for advanced manufacturing, aerospace, and energy transition markets [3]. - NioBay is engaged in research partnerships with universities to support technical studies and the development of new technologies for niobium [3].

Core Viewpoint - NioBay Metals Inc. is committed to conducting its exploration program for the James Bay niobium project in a manner that respects the rights of the Moose Cree First Nation and complies with environmental laws and regulations [2][4]. Group 1: Company Commitment and Community Engagement - The company emphasizes its dedication to working collaboratively with the local community by utilizing local contractors, creating jobs, forming strategic partnerships, and contributing to community development [3]. - NioBay acknowledges that the James Bay Niobium Project is located within Treaty 9 territory, recognizing the Indigenous rights and interests of the Moose Cree and other Treaty 9 communities [4]. Group 2: Project Overview and Environmental Responsibility - NioBay aims to lead in the development of mines that prioritize low carbon consumption and responsible management of water and wildlife, focusing on environmental sustainability and social responsibility [5]. - The company holds a 100% interest in the James Bay Niobium Project, situated 45 km south of Moosonee, Ontario, and also has a 72.5% interest in the Crevier Niobium and Tantalum project in Québec [5]. Group 3: Niobium Industry Insights - Niobium is a ductile and malleable metal known for its high resistance to corrosion, enhancing the properties of materials used in various sectors, including Mobility, Structural, and Energy [6]. - The addition of niobium to materials like steel, glass, and aluminum castings improves efficiency and reduces environmental impacts, thereby increasing their value [6].

Group 1 - U.S. stock futures showed mixed results, with Dow futures declining approximately 0.1% [1] - Netflix reported fourth-quarter financial results that exceeded expectations but provided first-quarter guidance that fell short of estimates, leading to a significant drop in its stock price [2] - Netflix anticipates first-quarter revenue of $12.16 billion, slightly below the consensus estimate of $12.19 billion, and expects earnings per share of 76 cents, which is below the consensus estimate of 81 cents [2] Group 2 - Erasca Inc shares fell 6.2% to $9.20 following the announcement of a proposed public offering of $150 million [3] - Telix Pharmaceuticals experienced a 5.8% decline to $7.28, despite an analyst maintaining a Buy rating with a $20 price target [3] - Corvus Pharmaceuticals saw a 5.6% drop to $20.22 after commencing a $150 million offering of common shares and pre-funded warrants [3] - BIOAGE Labs Inc shares decreased by 5.6% to $20.13 after announcing a $75 million stock offering [3] - Kraft Heinz Co shares fell 5.3% to $22.51 after Berkshire Hathaway filed to sell up to 325 million shares of the company [3] - NovaBay Pharmaceuticals Inc shares dropped 5.2% to $6.16, following a 56% decline on Tuesday due to a $100 million ATM equity program announcement [3] - Okeanis Eco Tankers Corp shares decreased by 4.8% to $37.00 in pre-market trading [3]